Article

TILRAY CEO says vaping illness outbreak could lead to marijuana legalization.

November 13, 2019

 

The deadly lung illness linked to vaping could prompt the United States and others to legalize marijuana, Tilray CEO Brendan Kennedy disclosed. “All the products that we produce in Canada and produce around the world are well tested by not only Health Canada, but regulators in other countries. One could argue this vaping crisis could lead to more legalization.”

 

Health officials are calling the disease EVALI, short for e-cigarette, or vaping, product use associated lung injury. Most patients have reported vaping THC, the active ingredient in marijuana, according to the Centers for Disease Control and Prevention (CDC). The latest national and state findings suggest products containing THC, particularly those bought off the street or from other informal sources, are linked to most of the cases, the CDC said.

 

To date, the CDC has confirmed 2,051 probable vaping illness cases and 39 deaths. The CDC doesn’t know exactly what’s making people sick, but health officials say they are narrowing in on vitamin E acetate, a compound found in some THC vaping products.

Canada is the first G-7 country to legalize recreational marijuana. Only 11 states in the U.S. and the District of Columbia have legalized cannabis for recreational use.

 

Marijuana advocates, in recent months, have renewed calls for legal and regulated marijuana amid the vaping outbreak. They say regulation of the substance will make people safer.

 

___

 

 

Tilray, Inc. (TLRY) $21.45

 

click

https://finance.yahoo.com/quote/TLRY?p=TLRY&.tsrc=fin-srch

 

 

Kennedy also confirmed more operating losses for the company. Tilray reported third-quarter financial results, which reported a loss of 36 cents on revenue of $51.1 million. 

 

As suggested, SP+GTM algorithm predicted the Tilry results with more losses ahead. Stay away from this pot play!

 

SP+GTM algorithm predicted*

     BUY  @ $25 with technical move to $150.

     BUY @ $150 with technical move to $300.

     SELL @ market when in $290 to $300 range.

     SELL SHORT @ $291.

     COVER SHORT SALE @ $150.

     SELL SHORT @ $125 with technical decline to $20.

 

* Every suggestion  confirmed on our news reporting pages and social media.

 

 

 

 

 

 

 

 

Please reload

Recent Posts

December 4, 2019

Please reload

Archive

Please reload

Tags

Please reload

Legal | Privacy

©2019 by first jersey cannabis corp.